Back | Next |
home / stock / dyai / dyai message board
Subject | By | Source | When |
---|---|---|---|
zacks definitely was on the call | Paullee | investorshub | 03/30/2022 3:18:50 PM |
Hi, The recap seemed like other investor presentations. | blue_skies | investorshub | 03/30/2022 1:06:47 PM |
shortest call he ever had. The one question | Paullee | investorshub | 03/29/2022 10:36:32 PM |
Anyone listening to the CC? Your thoughts? | blue_skies | investorshub | 03/29/2022 9:22:48 PM |
$DYAI is not mentioning money because there is | blue_skies | investorshub | 03/25/2022 4:17:30 PM |
My fear is that $DYAI will not have | blue_skies | investorshub | 03/25/2022 1:09:54 PM |
Price has been dropping on minimal volume | natec22 | investorshub | 03/23/2022 11:34:04 PM |
Everybody waiting on earnings..waiting to see if one | natec22 | investorshub | 03/23/2022 11:20:56 PM |
Well, the $SRNE just fell apart. He | Paullee | investorshub | 03/21/2022 10:39:12 PM |
Paullee, | blue_skies | investorshub | 03/21/2022 7:02:18 PM |
why would you think it was ever back on? | blue_skies | investorshub | 03/18/2022 10:18:29 PM |
as expected, $DYAI and$ SRNE deal is off | Paullee | investorshub | 03/18/2022 8:24:56 PM |
you could probably skip the first 20 minutes | Paullee | investorshub | 03/14/2022 9:57:01 PM |
If you want to hear Mark speak again | Paullee | investorshub | 03/14/2022 9:04:33 PM |
If the Bruins(from New England here) had this | blue_skies | investorshub | 03/08/2022 7:13:31 PM |
For all $DYAI's talk (shots on net) | blue_skies | investorshub | 03/08/2022 6:20:03 PM |
nope, it wasn't $DYAI | Paullee | investorshub | 02/17/2022 6:15:43 PM |
Sorrento Therapeutics just got a 45 mil loan. | Paullee | investorshub | 02/16/2022 10:52:23 PM |
PHAC up over 7% and $DYAI can't catch | Paullee | investorshub | 02/10/2022 3:52:36 PM |
The street is waiting for the money | natec22 | investorshub | 02/10/2022 3:41:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Dyadic International Inc. Company Name:
DYAI Stock Symbol:
OTCMKTS Market:
Dyadic International Inc. Website:
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for ...
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well a...
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant protein receptor binding domain booster vaccine candidate for protection against C...